Personalis, Inc. (PSNL)
10.17
-1.08
(-9.60%)
USD |
NASDAQ |
Jan 23, 16:00
10.41
+0.24
(+2.36%)
Pre-Market: 20:00
Personalis EPS Diluted (Quarterly): -0.2441 for Sept. 30, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Intellia Therapeutics, Inc. | -0.9196 |
| Hologic, Inc. | 0.8298 |
| Pacific Biosciences of California, Inc. | -0.1263 |
| Twist Bioscience Corp. | -0.4491 |
| Ionis Pharmaceuticals, Inc. | -0.805 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -21.65M |
| Revenue (Quarterly) | 14.50M |
| Total Expenses (Quarterly) | 36.15M |
| Enterprise Value | 794.50M |
| Gross Profit Margin (Quarterly) | 13.20% |
| Profit Margin (Quarterly) | -149.4% |
| Earnings Yield | -8.62% |
| Normalized Earnings Yield | -8.616 |